​

Funding Round

Series C - Abionic

Series C - Abionic

Investment Firm

Overview

Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.

Announced Date

Mar 28, 2018

Funding Type

Series C

Highlights

Location

Switzerland, Europe

Social

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorPeter Letmathe
Participant InvestorZürcher Kantonal Bank
Participant InvestorVerve Ventures
Participant Investor3wVentures
Participant InvestorArkady Volozh

Round Details and Background

Abionic raised $20907883 on 2018-03-28 in Series C

Abionic is ideally positioned at the boundaries of medical technology, biotechnology and nanotechnology.

Company Funding History

9

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 03, 2010
Pre Seed Round - Abionic
1-102.3K
Jun 13, 2023
Grant - Abionic
1-82.8K
Apr 26, 2012
Series A - Abionic
5-2.2M
Oct 14, 2014
Series B - Abionic
2-4.0M

Recent Activity

There is no recent news or activity for this profile.